Details for Patent: 8,821,920

Which drugs does patent 8,821,920 protect, and when does it expire?

Patent 8,821,920 protects QUTENZA and is included in one NDA.

This patent has thirty-two patent family members in twenty-three countries.

Summary for Patent: 8,821,920

Title:	Therapeutic patch for transdermal delivery of capsaicin
Abstract:	The invention relates to a topical patch comprising a therapeutic compound-impermeable backing layer, a self-adhesive matrix based on polysiloxanes and containing capsaicin or a therapeutic compound analogous to capsaicin, and a protective film to be removed before use, in which the matrix contains liquid microreservoirs based on an amphiphilic solvent, in which the therapeutic compound is present in completely dissolved form and the concentration of the therapeutic compound in the microreservoir droplets is below the saturation concentration. The invention furthermore relates to a process for its production and its use in the treatment of neuropathic pain.
Inventor(s):	Muller; Walter (Andernach, DE)
Assignee:	LTS Lohmann Therapie Systeme AG (Andernach, DE)
Application Number:	10/823,119
Patent Claim Types: see list of patent claims	Use; Formulation; Compound;

Drugs Protected by US Patent 8,821,920

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes			Y

International Family Members for US Patent 8,821,920

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	363900
Australia	2003289710
Brazil	0318250
Brazil	PI0318250
Canada	2517493